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INTRARATER AGREEMENT OF ELBOW EXTENSION RANGE OF MOTION 1 
IN THE UPPER LIMB NEURODYNAMIC TEST 1 USING A SMARTPHONE 2 
APP 3 
 4 
 5 
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ABSTRACT 7 
 8 
 9 
Objective: To estimate the intrarater agreement of the Compass application of 10 
a smartphone (iPhone 4) in the assessment of the elbow extension range of 11 
motion (EE–ROM) at pain onset and maximum tolerable point during the upper 12 
limb neurodynamic test 1 (ULNT1). 13 
Design: Within-day intrarater agreement study. 14 
Setting: Private and university clinical settings. 15 
Participants: 41 volunteers (age = 31.34 ± 13.27 years, 21 males, height = 16 
1.67 ± 0.07m, and body mass = 70.53 ± 12.37kg) recruited from the community, 17 
with no symptoms or musculoskeletal abnormalities in their upper body 18 
quadrant and no regional or systemic nerve dysfunction. 19 
Interventions: Not applicable  20 
Main Outcome Measures: 95% limits of agreement (95% LoA), standard error 21 
of the measurement (SEM) and minimal detectable change (MDC95) of elbow 22 
extension range of motion (EE–ROM) at pain onset and maximum tolerable 23 
point during the ULNT1. 24 
Results: SEM and MDC95 were relatively high on both sides when considering 25 
the onset of pain (SEM=6.6–6.8º; MDC95=18.4–18.8º). Better results were 26 
found for the maximum tolerable point (SEM = 4.2–4.8º; MDC95 = 11.7–13.2º). 27 
The 95% LoA showed a similar trend. 28 
Conclusion: Smartphone measurements showed relatively wide agreement 29 
parameters of elbow extension during the ULNT1. These results are, 30 
nevertheless, comparable to previous studies using goniometric assessment 31 
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when considering maximal pain tolerance. Further research is needed before 32 
the possible widespread use of the smartphone in neurodynamic assessment.  33 
 34 
Key Words: outcome measurement error; pain thresholds, peripheral nerves, 35 
range of motion 36 
  37 
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List of abbreviations  38 
CI confidence intervals 39 
EE–ROM elbow extension range of motion 40 
GRRAS guidelines for reporting reliability and agreement studies 41 
LoA limits of agreement 42 
MDC minimal detectable change 43 
SEM standard error of the measurement 44 
ULNT1 upper limb neurodynamic test 45 
 46 
 47 
The neurodynamic tests of the upper limb are routinely used during physical 48 
examination to evaluate the involvement of neural tissues in pain mechanism 49 
and disability of the upper body quadrant1, 2. They consist of a sequence of 50 
movements of the upper body segments that exert mechanical forces to a 51 
portion of the nervous system, gradually causing motion and tension in those 52 
neural structures3, 4. A positive sign of neural involvement is present when the 53 
neurodynamic test reproduces, at least partially, the patient’s pain and this 54 
response is altered by a differentiating maneuver5, 6. Side-to-side differences in 55 
range of motion and/or in sensory responses may also be indicative of the 56 
presence of a neural component in the pathogenesis of pain and disability4, 5, 7. 57 
One standard neurodynamic test for the upper limb is directed at the median 58 
nerve and/or brachial plexus, also known as the upper limb neurodynamic test 1 59 
or simply ULNT13, 4 (Figure 1). In high mechanosensitive tissues, it is expected 60 
that a greater response (ie, hypersensitivity, hyperalgesia, or more resistance to 61 
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motion due to muscle spasm) occurs which stops the elbow extension range of 62 
motion (EE–ROM) at an earlier phase during the test and/or determines its 63 
end8. For this reason, the assessment of EE–ROM frequently complements the 64 
diagnostic criteria mentioned above and is used to evaluate the effects of 65 
interventions6-9.  66 
 67 
Several measurement instruments are available to assess the movements of 68 
body segments in space. These include universal goniometers, inclinometers, 69 
electrogoniometers, imaging techniques including medical imaging, and 6 70 
degrees of freedom motion tracking devices (eg, Table 1). However, most of 71 
these instruments are expensive, time-consuming, of limited portability and 72 
some of them require more than one examiner to perform the measurement, 73 
making it difficult to use them in different clinical contexts. Innovative solutions, 74 
such as the use of smartphones, have been suggested to overcome these 75 
limitations10, 11. At present, most smartphones have embedded motion sensors 76 
(eg, triaxial accelerometers, electro-mechanical gyroscopes, magnetometers) 77 
which, through software applications, allow real time detection and 78 
quantification of linear and angular motion of the device in the three planes of 79 
orientation. A number of studies have shown that smartphone measurements 80 
provide, in general, valid and reliable results for the evaluation of curvatures 81 
and movements of the spine and the orientation and range of motion of different 82 
segments and joints of the upper and lower limbs10, 12-18. Furthermore, as they 83 
are easy-to-use, portable and frequently used by clinicians for communication 84 
purposes, smartphones have the potential to assist these professionals in 85 
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clinical decision-making and evaluation of interventions both inside and outside 86 
the clinics without involving significant costs. However, smartphone 87 
measurement properties have never been tested during neurodynamic 88 
assessment.  89 
 90 
The purpose of this study was to therefore estimate the intrarater agreement 91 
properties of the Compass application of a smartphone (iPhone 4) in the 92 
assessment of the EE-ROM at pain onset and maximum tolerable point during 93 
the ULNT1. 94 
 95 
METHODS 96 
 97 
 98 
Study design  99 
A within-day intrarater agreement study was conducted. The study was 100 
registered at ClinicalTrials.gov (NCT02159924) and is reported according to the 101 
general guidelines for reporting reliability and agreement studies (GRRAS) 19.  102 
 103 
Ethical Approval Statement 104 
The study protocol was approved by the Ethics Committee of ICBAS-UP, 105 
Portugal (Project n. 064/2014).  106 
 107 
Participants 108 
Adults without impairments/limitations were recruited to participate in the study. 109 
Recruitment was conducted using the dissemination channels of the 110 
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management services of an academic organization in the central region of 111 
Portugal (Leiria). The aims, procedures and eligibility criteria of the study were 112 
provided. Inclusion criteria included being ≥ 18 years old and able to move all 113 
upper body quadrant joints in a normal ROM without any pain or movement 114 
restriction. Participants were excluded if they presented: musculoskeletal 115 
abnormalities in the upper body quadrant; any complaints in that region over the 116 
past 3 months; health conditions that may disrupt nerve function (eg, diabetes); 117 
leg length discrepancy of more than 1.5 cm 20; or cognitive impairment. Given 118 
the limited number of answers received through the dissemination channels 119 
abovementioned (n = 15) after 2 months of recruitment, a number of 120 
participants were brought into the study through snowball sampling in two 121 
physical therapy private clinics in Oporto, Portugal. 122 
 123 
All participants were informed about the aims and procedures of the study and 124 
of their right to withdraw at any time during the study. A physical therapist with 125 
17 years of clinical experience in musculoskeletal and neurodynamics 126 
evaluation ensured that the participants met the eligibility criteria. The 127 
assessments were undertaken at the places where the recruitment was held, 128 
from June to August 2014. Written informed consent was obtained from each 129 
participant before data collection and their rights protected. 130 
 131 
Instrumentation 132 
To assess EE-ROM, a smartphone with built-in sensors that measure the 133 
position and orientation of the device in the space (iPhone 4, iOS 7.2, Apple 134 
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Inc., Cupertino, CA) was used. Measurements were undertaken with a native 135 
application of the iPhone 4 operating system, the Compass app, in compass 136 
vision mode. This hardware/software set has demonstrated good validity criteria 137 
and intrarater reliability results when measuring body movements in the 3 138 
planes of orientation 21. 139 
 140 
Procedures 141 
Sociodemographic information (age, gender), height and body mass were first 142 
collected to characterize the sample. Measurements of the EE–ROM during the 143 
ULNT1 were then conducted using the smartphone. Participants were asked to 144 
remain in the supine position close to the border of a massage table, with the 145 
lower limbs straight, the body aligned and the upper limbs in neutral position. 146 
The head and neck were stabilized in maximum comfortable contralateral side-147 
flexion using a 5kg sand bag (Figure 1). One examiner (an experienced 148 
physical therapist) performed the measurements twice on both sides. A resting 149 
period of 5–10 minutes was allowed between measurements. The smartphone 150 
was coupled to the participant’s forearm using an armband with an extended 151 
Velcro strip to tightly adjust the smartphone (Figure 1). Before each test, the 152 
examiner assessed the quality of smartphone coupling (eg, avoiding armband 153 
slip during elbow extension) to ensure consistency of the measurements. All 154 
participants underwent a practice trial in the contralateral side prior to the first 155 
measurement which included performance of the ULNT1 movement sequence 156 
and a structural differentiating maneuver (returning contralateral cervical side-157 
flexion to the midline). With this procedure, participants could become familiar 158 
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with the mechanosensations (eg, pain or paresthesia, stretch) that may occur 159 
during the ULNT1 and could identify the sensory responses they should report 160 
during the test – the onset of pain and the maximum tolerable point. ‘Onset of 161 
pain’ was described as ‘the moment when the least experience of 162 
discomfort/pain was recognized’ whereas ‘maximum tolerable point’ was 163 
defined as ‘the greatest level of discomfort/pain which the subject was prepared 164 
to tolerate’22. Measurements were conducted by the same researcher, with 17 165 
years of clinical experience in musculoskeletal and neurodynamics evaluation. 166 
The ULNT1 sequence was performed in the following order, reaching the 167 
recommended range of motion of each segment without leading to discomfort or 168 
compensatory movements in the adjacent segments4: (1) maximal contralateral 169 
cervical side-flexion; (2) arm at 90° of shoulder a bduction preventing scapular 170 
elevation; (3) 90° of shoulder external rotation an d 90º of elbow flexion (this 171 
position defined the 0º of testing range of motion); (4) maximal forearm 172 
supination; (5) maximal extension of the wrist and fingers; and (6) elbow 173 
extension. This sequence was selected in order to constrain the movement of 174 
the forearm within the same plane of orientation (horizontal plane, forearm and 175 
hand moving parallel to the ground) consistently throughout elbow extension. 176 
Small deviations of the forearm/smartphone coupling from this plane were 177 
expected because the flexion/extension axis of the elbow is a loose hinge joint, 178 
involving 3-dimensional motion23, 24. The examiner was able to monitor such 179 
deviations on the device with the Compass app. Participants were instructed to 180 
inform the examiner when pain onset and maximum tolerable point occurred 181 
during elbow extension, the latter indicating the end of the test. Then, the 182 
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examiner registered the angular positions related to these events in 183 
independent recording sheets, for each measurement. In practice, neither the 184 
examiner nor the participant had access to the values of EE-ROM, since they 185 
were subsequently calculated by the difference between the initial and final 186 
angular positions registered.  187 
 188 
Data analysis 189 
Descriptive statistics were used to characterize the sample and to provide the 190 
scores of each test. Intrarater agreement of the EE-ROM using the smartphone 191 
was assessed at the onset of pain and at the maximum tolerable point of the 192 
ULNT1. The following agreement parameters were used: the standard error of 193 
the measurement (SEM), the minimal detectable change at the 95% level of 194 
confidence (MDC95, also known as the repeatability coefficient or the smallest 195 
real difference), and the 95% limits of agreement (95% LoA) and its precision 196 
estimates. SEM was calculated as follows (equation 1):  197 
 =  √2⁄  (1) 
in which  represents the standard deviation of the mean of the differences 198 
() between the two measurements performed on each side25. The SEM was 199 
then used to determine the MDC95 (equation 2)25, 26, representing the minimum 200 
amount of change in a participant’s EE-ROM that can be considered as a “true 201 
change”: 202 
95 = 1.96 ∗ √2 ∗  (2) 
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The 95% LoA delimit the extremes within which the differences between the two 203 
measures will be located in 95% of the times, which are thus comparable to the 204 
MDC95. The LoA were defined as follows (equation 3)26: 205 
95% = ̅ ± 1.96 ∗  (3) 
Precision of the estimated LoA were calculated accordingly26, using the 95% 206 
confidence intervals (CI) of the bias (equation 4) and 95%CI for the limits of 207 
agreement (equation 5): 208 
95%̅ = 	 ̅ ± !"# − 1% ∗ ̅ (4) 
where the standard error of the bias () was defined as ̅ =  √#⁄   209 
95%"% = 	 ± !"# − 1% ∗ "95%% (5) 
where the standard error of the 95%LoA was defined as "95%% =210 
1.71"̅%. These indicate how large the (dis)agreement between two 211 
measurements will be in 95% of the occasions.  212 
Analyzes were carried out using GraphPad Prism 6.0 (GraphPad Software, Inc., 213 
La Jolla, CA).  214 
 215 
RESULTS 216 
 217 
 218 
Participants 219 
All of the 41 volunteers met the eligibility criteria and thus were included in the 220 
study. Participants had a mean (±SD) age of 31.34±13.27 years (21 males, 221 
51.2%), height of 1.67±0.07m and body mass of 70.53±12.37kg. The right side 222 
was the dominant side for most participants (n = 35; 85.4%). 223 
  224 
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Intrarater agreement 225 
Table 1 shows the descriptive statistics and the estimates of the agreement 226 
parameters of the EE-ROM at the onset of pain and at the maximum tolerable 227 
point of the ULNT1, for the dominant and non-dominant limbs. The SEM and 228 
MDC95 were relatively high on both sides when considering the onset of pain 229 
(SEM = 6.6–6.8º; MDC95 = 18.4–18.8º). Better results were found when the 230 
maximum tolerable point of the test was identified (SEM = 4.2–4.8º; MDC95 = 231 
11.7–13.2º). The 95% LoA showed a similar trend, with narrower agreement 232 
limits for the maximum tolerable point. The 95% LoA results are presented in 233 
Table 2 and Figure 2. No systematic bias was found in the measurements 234 
performed.  235 
 236 
The precision of the inferior limit of agreement at the onset of pain was 237 
approximately ±5º, being (-11.9º, -22.1º) and (-15.9º, -26.3º) for the dominant 238 
and non-dominant limb, respectively. The same trend was found for the upper 239 
limit: (14.7º, 24.9º) on the dominant side and (11.2º, 21.6º) on the non-dominant 240 
side. The 95%CI of the bias between the two measurements were (-1.6º, 4.3º) 241 
and (-0.7º, 5.4º) for the dominant and non-dominant sides, respectively. For the 242 
maximal tolerable point, the precision of the LoA was narrower (±3º). For the 243 
inferior limit, the 95%CIs were (-8.9º, -16.1º) for the dominant side and (-8.9º, -244 
15.3º) for the non-dominant side. For the upper limit, they were (10.4º, 17.6º) 245 
and (8.1º, 14.5º), for the dominant and non-dominant sides, respectively. The 246 
95%CI for the bias were (-1.4, 2.9º) for the dominant side and (-2.3º, 1.5º) for 247 
the non-dominant side. 248 
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 249 
DISCUSSION 250 
 251 
 252 
To the best of the authors’ knowledge, this was the first study to investigate the 253 
intrarater agreement parameters of a smartphone application in the assessment 254 
of the EE-ROM during the ULNT1. Relatively wide agreement parameters were 255 
observed when determining the EE-ROM at the onset of pain, with narrower 256 
estimates found at the maximum tolerable point. Findings suggest that 257 
smartphone measurements may have potential for clinical purposes when 258 
considering EE-ROM and maximum pain tolerance as the assessment criterion.  259 
 260 
In the present study, estimates of the measurement error (SEM) and the 261 
minimal amount of change necessary to assume a meaningful change in 262 
patient’s performance (MDC95) were relatively low at the maximum tolerable 263 
point. Previous studies assessing the EE-ROM during the ULNT1 at maximum 264 
pain tolerance, using an electrogoniometer22, 27 or a camera-based 6 degrees of 265 
freedom motion tracking device28, have shown even lower measurement error 266 
(SEM = 0.97º–2.59º) than the present study (Table 1). It is known that this type 267 
of equipment is paramount in providing accurate and reliable results under 268 
laboratory conditions (eg, instrumental constraint of movements of the body 269 
segments during the maneuver); however, such devices and conditions are not 270 
available or unpractical to use in most clinical settings; therefore, their 271 
usefulness in clinical practice is of questionable value. Despite that, results from 272 
the present study were comparable to the results obtained in a study performing 273 
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the same measurement with a universal goniometer29 (SEM = 4.2º–4.8º vs. 274 
SEM = 3.91º–6.02º; MDC = 11.7º–13.2º vs. MDC = 10.93º–16.70º, 275 
respectively). These findings are encouraging, since they suggest that 276 
measurement of the EE-ROM at maximum pain tolerance during the ULNT1 277 
can be performed in the clinical setting by either using a smartphone or a 278 
universal goniometer without a substantiated difference in the measurement 279 
error. Previous studies comparing measurements of joints ROM between 280 
smartphones and universal goniometers have found high correlations (r = 0.79–281 
0.9910, 16-18) and good agreement results15-17. Considering the availability, 282 
portability and the reduced number of human resources needed to perform 283 
measurements (ie, it requires only one person to conduct both the test and the 284 
measurements), smartphones may have the potential to be widely used in the 285 
future for measuring the EE-ROM during the ULNT1 in the clinical context.  286 
 287 
Regarding the onset of pain, the SEM and MDC95 were relatively high and the 288 
95% LoA were wider in both sides, when compared to the maximum tolerable 289 
point. Coppieters et al22 found a similar trend using electrogoniometer 290 
measurements in a sample of asymptomatic subjects, with the SEM of 291 
‘submaximal pain’ being better than the ‘onset of pain’. It is likely that these 292 
results are related to less accurate perception of a light pain, as subjects 293 
experience at “pain onset”, comparatively to the more intense experience at 294 
“maximum tolerable point”. Further research is needed to explore this issue. 295 
Furthermore, previous studies assessing the EE-ROM during the ULNT1 at the 296 
onset of pain using goniometers and electrogoniometers have shown a lower 297 
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measurement error than in the present study (Table 1)22, 30, 31, with the SEM 298 
ranging from 3.0º22 to 4.02º30. This finding suggests that care must be taken 299 
when using the smartphone to measure EE-ROM during the ULNT1 at pain 300 
onset. Future research is warranted to compare measurements conducted with 301 
smartphones and (electro)goniometers. 302 
The Compass app used in the present study is the smartphone's native 303 
application primarily intended for recreational use; however, this study aimed to 304 
assess its potential applicability to measure EE-ROM during the ULNT1 based 305 
on the premise that any physical therapist using the smartphone could easily 306 
use this application to measure ROM. Nevertheless, it is not specific to measure 307 
joints ROM and thus it lacks specific features which are important for clinical 308 
practice, such as the automatic calculation of the joint ROM, the selection of the 309 
joint, side, position of the body segment, type of motion (ie, flexion, extension, 310 
abduction, etc.), or the memory of the joint ROM by date, time and patient. 311 
Currently, there are various paid applications designed to measure joints ROM 312 
on real-time (eg, GetMyROM32, Simple Goniometer18, Clinometer10, 15, 21). Their 313 
agreement properties have been tested while assessing the ROM of the 314 
shoulder15, 32, knee18 and cervical spine21. However, to the authors’ knowledge, 315 
no study has examined the EE-ROM during the ULNT1, as performed in this 316 
study. Future research should investigate the measurement properties of 317 
goniometer-based apps in the assessment of the EE-ROM during the ULNT1. 318 
 319 
Limitations 320 
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This study had some limitations that need to be acknowledged. First, the results 321 
cannot be generalized because the sample was composed of adults without 322 
impairments or limitations. Further research should also assess the 323 
measurement properties of smartphone measurements in populations with 324 
nerve-related pain and disability of the upper limb, since they may show a 325 
higher measurement error in EE-ROM during the ULNT1 than populations 326 
without impairments/limitations22.  327 
Second, in the present study, the measurements were conducted in the same 328 
day; however, a previous investigation using an electrogoniometer to measure 329 
the EE-ROM has shown that between-day agreement is frequently lower than 330 
the within-day agreement22. This should be explored in future studies using the 331 
smartphone. Third, the present study assessed the intrarater agreement of the 332 
smartphone to measure EE-ROM during the ULNT1 without instrumental 333 
constraint or measurement of the movements of the upper body quadrant 334 
segments, as currently performed in the clinical setting. Before the possible 335 
widespread use of this technology in the clinical environment, though, further 336 
research needs to be conducted to more definitively discern its value, 337 
specifically: (a) to compare the EE-ROM measurements from the smartphone 338 
and a clinical (eg, goniometer) and laboratorial (eg, 6 degrees of freedom 339 
motion tracking devices) ‘gold standard’ under the same and other testing 340 
conditions (eg, different sequences, adding/removing structural differentiating 341 
maneuvers) to assess the concurrent validity of smartphone measurements; (b) 342 
to assess interrater agreement; (c) to explore the feasibility of using smartphone 343 
applications to measure the EE-ROM during the ULNT1 in different clinical 344 
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settings; (d) to establish the minimal clinically important difference of the EE-345 
ROM during the ULNT1 to better interpret the range of measurement error that 346 
can be accepted for clinical purposes. Finally, the application used in the 347 
present study is native to a specific smartphone and operating system 348 
manufacturer and thus its use is restricted to this environment. However, the 349 
applicability of smartphone measurements is likely extendable to other 350 
smartphones having motion sensors and different operative systems. 351 
 352 
CONCLUSIONS 353 
 354 
 355 
The wide availability and portability of smartphones make them an interesting 356 
alternative to the universal goniometers commonly used in clinical practice. The 357 
results of this study, together with previous studies, has shown that 358 
smartphones (particularly those using an iOS system) may have comparable 359 
agreement parameters to goniometry to assess the EE-ROM during the ULNT1 360 
when considering maximal pain tolerance. Nevertheless, much work still needs 361 
to be conducted before the possible widespread use of the smartphone to 362 
measure the EE-ROM during the ULNT1. 363 
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Figure Legends 469 
 470 
FIGURE 1. Measurement of the elbow extension range of motion during the 471 
upper limb neurodynamic test 1 using the smartphone: initial position (left 472 
image), onset of pain (center), and maximal tolerable (right image). The initial 473 
position defined the 0º of testing range of motion. 474 
 475 
FIGURE 2. The 95% limits of agreement of the elbow extension range of motion 476 
at the onset of pain and at the maximum tolerable point of the upper limb 477 
neurodynamic test 1, for the dominant and non-dominant sides. Points 478 
represent each of the participants. 479 
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TABLE 1. Studies analyzing the intrarater agreement of the elbow extension 
range of motion in asymptomatic subjects during the upper limb 
neurodynamic test 1 (ULNT1).  
Authors Participants Instrumentation Intrarater agreement 
Coppieters 
et al33 
n = 10, 5 
males, 23.4 
± 2.2 years 
old, all right 
handed  
 
Electrogoniometer Pain onset  
SEM: D = 3.0º ± 95% CI 6.0º 
Pain tolerance  
SEM: D = 2.3º ± 4.5º 
 
Lohkamp 
and 
Small29 
n = 20, 10 
males, 27.9 
± 6.2 years 
old, 
dominance 
not specified 
Goniometer Pain tolerance 
SEM: D = 3.91º, ND = 6.02º 
MDC: D = 10.93º, ND = 
16.70º 
Oliver and 
Rushton27 
n = 40, 11 
males, 23.4 
(18–42) 
years old, 
dominance 
not specified 
Electrogoniometer Pain tolerance* 
SEM: R = 0.97º– 2.59º 
MDC: R = 2.68º – 7.16º 
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Talebi et 
al27 
n = 23, 22.3 
± 2.3 years 
old, sex and 
dominance 
not specified 
Goniometer Symptoms or stretching 
onset* 
SEM = 3.1º 
Van Hoof 
et al28 
n = 36, 13 
males, 21.4 
± 0.3 years 
old, 31 right 
handed  
Camera-based 
motion tracking 
device 
Pain tolerance/ Maximal end 
resistance 
SEM: R = 2.26º, L = 1.97º 
MDC: R = 6.28º, L = 5.46º 
Stalioraitis 
et al30 
n = 51, 26 
males, 26.7 
± 5.9 years 
old, all right 
handed   
Electrogoniometer Symptoms onset 
SEM: R = 3.31º, L = 4.02º 
MDC: R = 9.17º, L = 11.14º 
Current 
study 
n = 41, 21 
males, 31.3 
± 13.3 years 
old, 35 right 
handed 
Smartphone  Pain onset  
SEM: D = 6.6º, ND = 6.8º 
MDC: D = 18.4º, ND =18.8º 
Maximum pain tolerance  
SEM: D = 4.8º, ND = 4.2º 
MDC: D = 13.2º, ND = 11.7º 
Abbreviations: D, dominant; L, left; MDC, minimal detectable change; ND, non-
dominant; R, right; SEM, standard error of measurement. Notes: In studies 
using variations of the ULNT1, findings are only displayed for the sequence of 
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the test that was similar to that of the present study, unless otherwise indicated. 
*The test was conducted with the cervical in neutral position. 
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TABLE 2. Descriptive statistics and agreement parameters of the elbow extension range of motion at the onset of pain and at the 
maximum tolerable point of the upper limb neurodynamic test 1. Values are displayed for the dominant (D) and non-dominant (ND) 
sides and presented in degrees (º). 
 Side mean ± SD of 
measurement 1 
(º) 
mean ± SD of 
measurement 2 (º) 
 of 
measurements 1 and 2 
(º) 
SEM (º) MDC95 (º) 95% LoA (º) 
Onset of pain D 36.0 ± 13.7 34.6 ± 13.1 1.4 ± 9.4 6.6 18.4 -17.0 – 19.8 
ND 33.3 ± 13.8 35.7 ± 10.4 -2.3 ± 9.6 6.8 18.8 -21.1 – 16.4 
Maximum 
tolerable 
D 61.3 ± 12.6 60.5 ± 12.8 0.8 ± 6.8 4.8 13.2 -12.5 – 14.0 
ND 59.2 ± 12.5 59.6 ± 12.3 -0.4 ± 6.0 4.2 11.7 -12.1 – 11.3 
Abbreviations: 95% LoA, 95% limits of agreement; , mean of the differences; D, dominant side; MDC95, minimal detectable change 
at the 95% level of confidence; ND, non-dominant side; SD, standard deviation; , standard deviation of the differences; SEM, 
standard error of measurement. 
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Highlights: 
• The smartphone app showed a relatively wide agreement of EE-ROM 
during the ULNT1; 
• A better agreement was found at maximal pain tolerance than at the 
onset of pain; 
• Results regarding maximal pain tolerance are comparable to those using 
goniometers. 
